[Treatment guidelines for the idiopathic nephrotic syndrome in children].
Yoshikawa
Norishige
N
Honda
Masataka
M
Sekine
Kouji
K
Nakanishi
Kouichi
K
Iijima
Issei
I
Ootomo
Yoshiyuki
Y
Ikeda
Masahiro
M
Wada
Naohiro
N
Nakamura
Hidefumi
H
Sako
Mayumi
M
D002648:Child; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage*; D016572:Cyclosporine / Q000008:administration & dosage*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008775:Methylprednisolone / Q000008:administration & dosage; D009404:Nephrotic Syndrome / Q000145:classification / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage*; D020551:Pulse Therapy, Drug; D012008:Recurrence; D012263:Ribonucleosides / Q000008:administration & dosage*
D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D016572:Cyclosporine; D003520:Cyclophosphamide; D011239:Prednisolone; D008775:Methylprednisolone